COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

Patent number:

No items found.

A composition and methods for treating metabolic disorders, such as hepatic steatosis, adipose tissue dysfunction, and insulin resistance. Small interfering RNAs (siRNAs) targeting LPS-binding protein (LBP) that include unlocked nucleotides (UNA) and their therapeutic applications for the treatment of metabolic disorders are provided herein.

Countries:

Spain

Regions:

Catalonia

Centers:

UNIVERSITAT DE BARCELONA, FUNDACIO INST D INVESTIGACIO BIOMEDICA DE GIRONA DR JOSEP TRUETA IDIBGI

Other entities:

Centro de Investigación Biomédica en Red (CIBER) ; ARCTURUS THERAPEUTICS INC

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

-First therapeutic approach using lipid nanoparticles with modified siRNA against liver LPS-binding protein (LBP) for therapy for obesity-associated metabolic disturbances. -LUNAR® system: demonstrated successful, safe and potent siRNA delivery system. -Long term treatment (6 months) with repeated LUNAR®-Lbp UNA-siRNA weekly doses is well tolerated by the mouse liver -Not adverses cytokine profile of mice treated with LUNAR®-Lbp UNA-siRNA in long treated mice -LUNAR®-Lbp UNA-siRNA administration might stimulate tissue macrophage recruitment associated with an anti-inflammatory phenotype

Comments

Other related patents

Health

SULFATED C19 STEROID HORMONES TO TREAT AND/OR PREVENT PROTEOTOXICITY IN PROTEIN-AGGREGATION DISEASES

Countries

Spain

Health

INTRA-OPERATIVE DISINFECTION OF BONE PROSTHESIS

Countries

Spain

Health

Medical Devices

OCULAR DRUG INCORPORATION VEHICLE, POLYMERIZATION MOLD AND PROCEDURE FOR OBTAINING SUCH OCULAR DRUG INCORPORATION VEHICLE

Countries

Spain

Get back to patents directory